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The Pu.1 target gene Zbtb11 regulates neutrophil
development through its integrase-like HHCC
zinc finger
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In response to infection and injury, the neutrophil population rapidly expands and then quickly
re-establishes the basal state when inflammation resolves. The exact pathways governing
neutrophil/macrophage lineage outputs from a common granulocyte-macrophage progenitor
are still not completely understood. From a forward genetic screen in zebrafish, we identify
the transcriptional repressor, ZBTB11, as critical for basal and emergency granulopoiesis.
ZBTB11 sits in a pathway directly downstream of master myeloid regulators including PU.1,
and TP53 is one direct ZBTB11 transcriptional target. TP53 repression is dependent on ZBTB11
cys116, which is a functionally critical, metal ion-coordinating residue within a novel viral
integrase-like zinc finger domain. To our knowledge, this is the first description of a function
for this domain in a cellular protein. We demonstrate that the PU.1–ZBTB11–TP53 pathway is
conserved from fish to mammals. Finally, Zbtb11 mutant rescue experiments point to a
ZBTB11-regulated TP53 requirement in development of other organs.
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T
rillions of neutrophils are required every day for host
defence. In response to threats like infection and injury, the
neutrophil population must be rapidly expanded1.
Maintaining steady-state production of short-lived, terminally
differentiated neutrophils and rapidly increasing their production
on demand requires tightly coordinated but flexible regulation2,3.
Neutrophil expansion relies on haemopoietic stem cell (HSC)-
derived common myeloid progenitors that can give rise
to macrophages as well as neutrophils4. Lineage choice is
determined by complex interplay of transcription factor
regulatory networks5,6. It is thought that low levels of Pu.1
contribute to development along the neutrophil lineage, with
contributions by C/ebpa and Gfi1, whereas high levels of Pu.1
together with Irf8 direct development along the macrophage
lineage. This occurs within the context of integral signalling
pathways, cytokines and epigenetic modifiers that act in concert
with transcription factors to regulate haemopoietic output.
Despite intensive study in this area, the precise mechanisms
governing neutrophil specification are still not known.
TP53 has long been synonymous with its central role as a
tumour suppressor and protector of genome integrity. Its
functional sphere of influence extends beyond this role, however,
and TP53 has a key role in HSC development. High levels of
TP53 are associated with HSC quiescence and expression of TP53
must be downregulated in order for HSCs to exit quiescence and
enter the cell cycle7,8. A hypomorphic Mdm2 allele, which results
in high levels of Tp53, causes profound lymphopenia and a
decrease in granulocytes to 60% of wild-type (WT) value9,
suggesting a differential developmental requirement for tightly
regulated Tp53 across haemopoietic lineages.
Zbtb11 (Zinc finger and BTB (broad-complex, tramtrack, bric-
a`-brac) domain containing 11) is an enigmatic member of the
ZBTB (BTB-ZF or POK—Pox virus and Kru¨ppel-like zinc
fingers) superfamily of B49 proteins characterized by the family
defining protein–protein interacting BTB domain and varying
numbers of zinc fingers10–12. The BTB domain in these proteins
can homodimerize or heterodimerize with cell-specific protein
partners including corepressors such as histone deacetylases
(HDACs) and a variable number of zinc fingers can mediate
DNA binding. Most ZBTB proteins are transcriptional repressors,
components of large multi-protein corepressor complexes that
bind target promoters and repress transcription. A minority of
ZBTB proteins can act as transcriptional activators, highlighting
their cell context-dependent potential for specificity13,14. Several
ZBTB proteins have important roles in haemopoiesis11,12
and oncogenic roles in promyelocytic leukaemia15,16. Previous
observations have correlated high ZBTB11 expression with
human myeloid lineage cells and several subtypes of acute
myeloid leukaemia17,18. Originally identified as a regulator of
metallothionein 2A 18 years ago19, little else is known about
Zbtb11 and its biological function.
Herein we define a biological function for Zbtb11 and provide
the first functional evidence for its role in myeloid lineage
development. We describe a new evolutionarily conserved genetic
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Figure 1 | mne presents a myeloid phenotype at 48 h.p.f. and maps to zbtb11. (a) Brightfield: enlarged fourth ventricle (arrow-head), small dark eye and
opacity due to CNS degeneration. Fluorescence: fewer mpx:EGFP-positive cells in mne compared to WT (enumerated in b). (b) Neutrophil deficiency,
reflected by the abundance of mpx:EGFP-positive cells, is exacerbated by increasing temperature in the temperature-sensitive mutant mne. Percentage of
neutrophils compared to WT is stated in the columns (data from one experiment (from left to right: n¼ 11, 12, 19, 12, 10, 11) representative of four
biologically independent replicates, two-tailed t-test; ****Pr0.0001). (c) Decreased expression of multiple myeloid genes in mne. Whole-mount in situ
hybridization of mne and WT siblings with neutrophil (mpx, lyz), myelomonocytic (lcp1, npsn1), and erythroid (hbbe3) markers at 48 h.p.f. (d) Summary of
marsanne genome scan data defining a region narrowed by positional cloning to a 50 kb critical interval, which contained a single gene, zbtb11. Sequencing of
mne zbtb11 identifies a single T4A transversion in exon 2 resulting in a Cys4Ser substitution at amino acid 116 (C116S); scale bars, 200mm (a,c).
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and biochemical pathway connecting the master myeloid
regulator PU.1 and ZBTB11 in basal neutrophil development
and emergency granulopoiesis, and show that early in haemopoi-
esis Zbtb11 is required for neutrophil but not macrophage
development. We identify ZBTB11 as a new transcriptional
repressor of TP53, pin-pointing key residues that are required for
ZBTB11 function as determinants of a novel N-terminal HHCC
(His, His, Cys, Cys) zinc finger and establish a Zbtb11–Tp53-
dependent pathway that regulates neuronal cell death.
Results
Marsanne is a Zbtb11 allele with a deficit in neutrophils. To
reveal new regulators required for myelopoiesis, we undertook a
forward genetic screen in ethylnitrosourea-mutagenized zebra-
fish, and identified marsanne (mne) as a temperature-sensitive
mutant with defective myeloid development evidenced by a def-
icit of cells expressing the neutrophil markers myeloperoxidase
(mpx) and lysozyme (lyz), and myelomonocytic markers
nephrosin (nspn1) and l-plastin (lcp1) (Fig. 1a–c; Supplementary
Fig. 1). A similar decrease in cell number across multiple myeloid
lineage genes pointed to a defect in the number of neutrophils
and not just aberrant expression of mpx (Fig. 1c). Erythromyeloid
progenitors are specified normally in mne and expression of
erythroid genes (for example, embryonic haemoglobin (hbbe3
and O-dianisidine staining)) is preserved for the life of the
embryo (5 days post fertilization (d.p.f.)), localizing the haemo-
poietic defect to the myeloid compartment (Fig. 1c;
Supplementary Fig. 2).
The mne mutation was positionally cloned and found to be a
T-A transversion resulting in a Cys to Ser change at amino acid
116 in the N-terminal domain of Zbtb11 (Fig. 1d). The
temperature sensitivity of the mutation indicated that the allele
was hypomorphic and the deficit in neutrophils could either
be augmented (33 C) or ameliorated (21 C) depending on
the temperature at which mne mutants were raised (Fig. 1b;
Supplementary Fig. 1). Standard genetic proofs including
morpholino-mediated phenocopy, mne rescue by overexpression
of WT but not mutant (C116S) Zbtb11 and independent non-
complementing CRISPR/Cas9-generated indel zbtb11 alleles
validated the positional cloning (Supplementary Fig. 3). Since a
biological function had not previously been ascribed to Zbtb11 we
set out to characterize its expression and function using genetic
mutants and biochemistry.
mne has impaired neutrophil development and differentiation.
Zbtb11 is maternally deposited and then widely expressed early in
development (Fig. 2a). After 24 hours post fertilization (h.p.f.), its
expression wanes at many sites but is retained in the nervous
system. Consistent with its expression pattern, mne also has a
multisystem embryonic lethal phenotype including impaired
craniofacial development (Fig. 2b) and hydrocephalus (Figs 1a
and 2c). Injection of rhodamine dye into the fourth ventricle
clearly shows its enlargement in mne compared to WT (Fig. 2c).
However, early in haemopoietic development when primitive
haemopoiesis prevails, mne displays a highly specific, lineage-
restricted, myeloid phenotype. Consistent specifically with the
myeloid-failure phenotype of mne, Zbtb11 is expressed in the
zebrafish haemopoietic intermediate cell mass (Fig. 2a). Several
pointers indicate an ongoing requirement for Zbtb11 in sustain-
ing definitive haemopoiesis. By 5 d.p.f., when there is strong local
expression of rag1-expressing T-cells in the thymus in the WT,
mne lacks rag1 expression in the thymus despite development of
the thymic primordia as marked by foxn1 (Fig. 2d). Thrombocyte
numbers are also reduced by 82 h.p.f. (Supplementary Fig. 2e).
Despite normal specification of HSCs, as defined by cells
expressing runx1 and myb along the ventral wall of the dorsal
aorta (Supplementary Fig. 2b), myb expression is absent in mne
caudal haemopoietic tissue at 72 and 96 h.p.f., suggesting that
maintenance of the stem cell pool is also disrupted in mne
(Supplementary Fig. 2c,d). This indicates a broader failure to
sustain definitive haemopoiesis later in development and high-
lights the sensitivity of granulocytes as the first lineage affected in
mne. PCR with reverse transcription (RT–PCR) of fluorescence-
activated cell sorting (FACS)-sorted adult zebrafish kidney mar-
row confirms expression of Zbtb11 in adult haemopoietic cells,
with highest levels in myeloid cells (Fig. 2e). Consistent with
public domain RNA expression profiles17,18, we have confirmed
that ZBTB11 protein is highly expressed in human Jurkat (T
cells), K562 cells (a BCR-ABL positive blast crisis
erythroleukaemia) and HL60 (promyelocytic leukaemia) cells
(Fig. 2f). Lower expression in HepG2 liver cancer cells correlates
with hepatocellular carcinoma expression profiling showing very
low ZBTB11 expression20. FACS-sorted embryonic neutrophils
from mne and WT stained with May-Gru¨nwald Giemsa exhibited
an abnormally higher proportion of immature neutrophils in
mne. Hence, there is both a quantitative and qualitative myeloid
development defect as a result of Zbtb11 dysfunction (Fig. 2g,h).
Zbtb11 is required for basal and emergency granulopoiesis.
The mne zbtb11 allele is temperature-sensitive, permitting the
severity of the phenotype to be altered by temperature shifts,
providing a gradient of low to high phenotypic severity with
increasing temperature. The neutrophil depletion phenotype
correlated strongly with an increasingly overall severe phenotype
in mne compared to WT (Supplementary Fig. 1a,b). As the
neutrophil deficiency in mne was not absolute, we examined
if stimulation of granulopoiesis could overcome the defect.
Freeze-killed T. marneffei fungal spores were injected as a global
microbial stimulus of granulopoiesis, resulting in strong aug-
mentation of the neutrophil population size in WT embryos,
but no rescue of the granulopoietic defect in mne (Fig. 3a,b). Even
when Zbtb11 function and basal neutrophil numbers were
partially restored by exploiting the temperature-sensitive mne
allele and raising the embryos at a lower temperature, emergency
granulopoiesis remained profoundly impaired (Fig. 3c).
Similarly, direct overexpression of colony stimulating factor 3a
(Csf3a/G-CSF), a haemopoietic growth factor relatively specific
for neutrophils, resulted in vigorous neutrophil expansion in
WT but failed to rescue the neutropenia of mne (Fig. 3d,e).
Collectively, these data identify intact mne locus function as a
genetic requirement for myeloid development that impacts the
neutrophil lineage during both homeostatic and emergency
granulopoiesis.
Since neutrophils and macrophages share a common progenitor,
the requirement for Zbtb11 in macrophage development was also
investigated. The temperature sensitivity of mne was used to
examine the requirement of Zbtb11 for macrophage development
across a range of phenotypic severities, with macrophages quantified
at restrictive (32 C), normal (28 C) and permissive (23 C)
temperatures. In all cases, the population sizes of macrophages
were not significantly different between mne and WT, showing that
at 48 h.p.f. Zbtb11 deficiency does not impair basal macrophage
development (Fig. 3f,g). In addition, macrophage replenishment
following ablation was not dependent on intact mne locus function
(Fig. 3h; Supplementary Fig. 4). At later time points (72–96h.p.f.),
macrophage numbers reduce inmne (Supplementary Fig. 4d), likely
reflecting the failure to sustain definitive haemopoiesis. The data
presented in Fig. 3, however, demonstrate that in primitive and
early in definitive haemopoiesis, there is a much greater require-
ment for intact mne function in the neutrophil lineage than there is
in the macrophage lineage.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14911 ARTICLE
NATURE COMMUNICATIONS | 8:14911 | DOI: 10.1038/ncomms14911 | www.nature.com/naturecommunications 3
Zbtb11 is a direct target of major myeloid regulators. Zbtb11-
dependent transcriptional networks and its upstream genetic
regulators have not been defined. To determine where Zbtb11 is
placed with regard to the known haemopoietic transcriptional
hierarchy, 2.9 kb of the human ZBTB11 promoter and 2.3 kb of
the zebrafish zbtb11 promoter were cloned and assayed for
activity in the presence and absence of increasing concentrations
of different human or zebrafish haemopoietic transcription
factors in 293 human embryonic kidney (HEK) cells. The myeloid
specification determinant Pu.1 (ref. 21) positively regulated both
zebrafish and human ZBTB11 promoter reporters, whereas the
erythroid transcription factor Gata1 did not (Fig. 4a,b), further
supporting a myeloid-specific role for ZBTB11. Likewise, GFI1
and C/EBPa transcription factors, also implicated in myeloid
specification22, respectively repressed and activated both
zebrafish and human ZBTB11 promoter reporters in a dose-
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Figure 2 | Zbtb11 expression and mne phenotype including delayed neutrophil maturation. (a) Whole-mount in situ hybridization (WISH) showing
widespread expression of Zbtb11 in the developing embryo up until 19 h.p.f., which becomes progressively restricted up until 80 h.p.f. Arrows indicate Zbtb11
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dependent manner (Fig. 4a,b). These findings are consistent with
published chromatin immunoprecipitation (ChIP) sequencing
data examining genome-wide loci occupancy for a series of
haemopoietic transcription factors including PU.1 and GFI1 in
mouse HPC7 haemopoietic progenitor cells23, and functionally
demonstrate regulation of the ZBTB11 promoter specifically by
these myeloid regulators. In addition, ChIP sequencing of mouse
granulocyte chromatin demonstrated PU.1 occupancy at the
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Zbtb11 locus (Fig. 4c) in granulocytes. In mne neutrophils,
canonical Pu.1 (Spi1b) expression is slightly elevated compared to
WT at 48 h.p.f. (logFC¼ 0.57; FDR¼ 0.043), which could
indicate Pu.1 modulation by a Zbtb11-mediated potential
negative feedback loop, though this remains to be explored.
Collectively, these data identify a new myeloid transcription
factor-ZBTB11 axis that is evolutionarily conserved in fish and
mammals.
TP53 is a direct ZBTB11 target. To understand gene regulatory
networks directed by Zbtb11 both globally and specifically in
neutrophils, WT and mne RNA were prepared from both whole
embryos and FACS-purified mpx-EGFP or lyz:dsRed-expressing
cells, and subjected to global RNA expression profiling. Tp53
was elevated in mne compared to WT in both analyses
(global (microarray): logFC¼ 3.5; neutrophils (RNA sequencing
(RNAseq)): logFC¼ 2.91, FDR¼ 0.0000001). Tp53 was of parti-
cular interest because of the known requirement for its down-
regulation during the maturation of haemopoietic lineages7,8. The
exquisite sensitivity and far-reaching consequences of TP53
activation are balanced by sophisticated multi-layered regulation
requiring stabilization, activation and release from Mdm2-
mediated targeting for degradation before invocation of TP53
transcriptional networks24,25. It was important to determine,
therefore, if upregulation of tp53 transcripts in mne was
accompanied by corresponding functional protein. The high
levels of the D113Tp53 alternative transcript shown by whole-
mount in situ hybridization (WISH) in mne indicate that the
upregulation of tp53 transcripts in mne results in stabilized
activated Tp53 protein capable of transactivating its target genes,
which include D113Tp53 (ref. 26). The increase in Tp53 protein
activity is localized strongly in the brain, particularly in the
cerebellum, the eye and mandibular mesenchyme (Fig. 4d).
Co-expression of human ZBTB11 significantly repressed a TP53
promoter-luciferase reporter in human 293 cells, suggesting a
direct interaction of ZBTB11 with the TP53 promoter (Fig. 4e).
ChIP of endogenous ZBTB11 in human erythroleukaemic K562
cells and of overexpressed mouse ZBTB11 in 293T HEK cells
confirmed occupancy at the TP53 promoter (Fig. 4f) further
supporting a direct, active role for ZBTB11 in transcriptional
regulation of TP53.
TP53 orchestrates genetic pathways signalling both cell death
and cell cycle arrest. To understand if either or both of these
mechanisms operate as a consequence of Zbtb11 deficiency, a
Tg(ubi:secA5-mVenus) reporter, in which Annexin 5-mVenus
expression serves as a marker for cell death, was crossed onto
mne. Quantification of Annexin 5þ cells demonstrated a
significant increase in global apoptosis in mne (Supplementary
Fig. 5b). This was associated with a corresponding cell cycle
arrest at 48 h.p.f. as measured by an almost complete absence
of EdU incorporation in mne (Supplementary Fig. 5c,d). We
hypothesized that if the Zbtb11/Tp53 interaction were function-
ally important in neutrophil development, Tp53 knockdown in
mne would restore neutrophil numbers. Taking advantage of the
extensive apoptotic cell death phenotype in mne, particularly in
the central nervous system, the Tg(lyz:dsRed;ubi:secA5-mVenus)
reporter was again employed. It also served as an internal control
to monitor efficacy of the tp53 translation blocking morpholino
used to knock down Tp53 levels, which would be predicted to
rescue any Tp53-dependent cell death phenotype. Indeed, the
abnormally high global cell death in mne embryos was normal-
ized to WT levels in mne tp53 morphants (Fig. 4g). The number
of neutrophils in mne tp53 morphants was also greater than in
control morphants (Fig. 4h). However, when this analysis was
repeated in mne on the tp53M214K/M214K DNA-binding mutant
background, the number of neutrophils was not significantly
different either at 2 or 5 d.p.f. regardless of tp53 status (Fig. 4i).
This suggests that mitigating the excessive over-expression of
Tp53 by morpholino knockdown may be beneficial for neutrophil
number in mne, however, complete removal of all transcription-
dependent Tp53 functions is not. Differences in coincident
Annexin V and lyz reporter expression were not detected between
mne and WT, suggesting that apoptosis of neutrophils is not
the major biological process underlying granulocyte deficiency at
this time point (Supplementary Fig. 5a). As an independent
measure of the biological relevance of the Zbtb11–Tp53 axis,
rescue of CNS cell death was scored in mne on both tp53 WT
and tp53M214K/M214K backgrounds (Fig. 4j). Across triplicate
experiments, CNS cell death was significantly rescued on
the tp53M214K/M214K background (Fig. 4k), but not the hydro-
cephalus and associated craniofacial defects typical of the mne
pleiotrophic phenotype. This suggests that the mne phenotype
is not due solely to a stress-response induction of Tp53,
rather Zbtb11 contributes by fine-tuning Tp53 during develop-
ment. Together these data establish the ZBTB11–TP53 axis as a
new, evolutionarily conserved pathway functionally contributing
to normal neutrophil development.
Zbtb11 Cys116 is key for HHCC domain and TP53 repression.
To unveil the biochemical mechanism underpinning the impact
of the C116S mutation on Zbtb11 function, we investigated
predicted structural motifs. Zbtb11 shares with other ZBTB
family members a conserved BTB domain thought to be impor-
tant for protein–protein interactions27 and 4 C-terminal zinc
finger double domains overlapping 12 predicted Kru¨ppel zinc
fingers. Unusually among ZBTB proteins, Zbtb11 has an extended
N-terminal domain with no recognized homology to predicted
motifs or function, yet this contains the mne C116S mutation.
Multiple sequence alignment of the region encompassing Cys116
revealed a paired His and Cys motif completely conserved across
species (Fig. 5a). These amino acids are positioned similarly to
those in the HHCC zinc finger in foamy virus integrase28,29 and
Figure 3 | Zbtb11 deficiency results in failure of emergency granulopoiesis. (a) Fluorographs of representative embryos either unstimulated (control) or
48 h post challenge with frozen T. marneffei spores. (b) Graph showing enumeration of neutrophils in embryos raised at 28 C; data from one representative
experiment of three biological replicates; each point represents one embryo (from left to right: n¼ 21, 24, 8, 13, 16, 11, 9, 20); mean±s.d., Mann–Whitney
test; ***Pr0.001; h.p.c., hours post challenge with frozen T. marneffei spores; (c) Enumeration of neutrophils raised at 22 C (arrow indicates the number of
unstimulated neutrophils in mne approaches that of WT at 22 C); details as for (b) (from left to right: n¼ 15, 16, 9, 13, 12, 16, 8, 12); one-tailed t-test;
***Pr0.001. (d) Overexpression of csf3a (G-CSF) results in vigorous stimulation of neutrophil expansion in WT but not mne embryos shown as
mpx-EGFPþ fluorescent neutrophils; ctrl, control; csf3 1 and csf3 2, 0.05 ng and 0.1 ng of csf3a mRNA, respectively. (e) Enumeration of neutrophils in d.
Mean ±s.e.m.; two-tailed t-test; n¼ 3 biologically independent experiments; **Pr0.01). (f) Fluorographs of representative WT Tg(mpeg1:mCherry) and
mne;mpeg1:mCherry embryos showing similar numbers of macrophages. (g) Enumeration of macrophages in f shows that at 48 h.p.f. macrophage
development remains unaffected regardless of severity of marsanne phenotype. n¼ 2 biologically independent experiments; mean ±s.e.m., two-tailed
t-test; NS¼ P40.05. (h) Macrophage development is independent of Zbtb11. Repopulation of macrophages following their selective ablation by
metronidazole (MTZ) treatment of Tg(mpeg1:Gal4FF/UAS:nfsb-mCherry/mpx:EGFP) embryos occurs in both Zbtb11 and control morphants. Details as for
b (from left to right: n¼ 18, 18, 7, 12, 14, 16, 6, 12); *Pr0.05; ***Pr0.001; h.p.t., hours post treatment; scale bars, 200 mm (a,d,f).
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identically to two human genes, GIN1 (gypsy retrotransposon
integrase-like protein 1)30 and NYNRIN (NYN domain and
retroviral integrase containing)31, forming a potential N-terminal
HX6H(X29)CX2C zinc finger motif (Fig. 5a). The functional
requirement for each of these conserved His/Cys residues was
tested using a series of Zbtb11 point mutants in an in vivo
bioassay based on mne rescue. Overexpression of Zbtb11 mRNA
with mutation of any or all four of the His/Cys residues failed to
rescue the mne phenotype (Fig. 5b,c). Wild-type Zbtb11 mRNAs
with no mutation or mutation of a non-conserved Gln98 residue
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(Fig. 5a,b) both rescued mne function. Hence, each of the four
residues of the HHCC motif is required for Zbtb11 function,
supporting its functionality as a discrete motif. Furthermore,
deletion mutants lacking the carboxyl-terminal zinc finger
domains were able to rescue (Fig. 5c), consistent with a prior
study demonstrating their dispensability for repression of the
metallothionein promoter19. Of note, deletion of the N terminus
did not interfere with functional rescue by Zbtb11 in this
bioassay, suggesting that the steric consequences of point
mutation of these four key residues are more detrimental to
whole protein function than complete absence of this domain.
To independently corroborate this observation about the
residual functionality of N-terminally deleted Zbtb11, cell cycle
progression was examined. Cell cycle progression, demonstrated
by EdU incorporation, presents an almost categorical phenotypic
difference between WT and mne, being present and absent,
respectively. Overexpression of N-terminally deleted Zbtb11 but
not the C116S mutant Zbtb11 again rescued mne gross
morphology and concomitantly restored cell cycling activity
(Supplementary Fig. 6).
To gain further insight into the impact of the C116S mne
mutation on Zbtb11 structure, three foamy virus integrase
structures complexed with manganese and containing an HHCC
motif similar to Zbtb11 (Fig. 5a) were used as a template for
homology modelling of zebrafish Zbtb11 amino acids 77–123.
This demonstrated a zinc finger structure in which each of the
conserved His/Cys residues including Cys116, coordinates the
metal ion (Fig. 5d).
To functionally examine the direct consequence of the T-A
(C116S) mne mutation on the ZBTB11-TP53 promoter interac-
tion, ZBTB11 was engineered to contain the C116S mutation and
co-transfected with a TP53 promoter-driven reporter. Compared
to WT ZBTB11, the mutant failed to show significant repression
of TP53 at any of the doses measured (Fig. 5e). Furthermore,
whereas WT ZBTB11 was found to regulate its own promoter,
mutation of C116S resulted in failure of this autorepression
(Fig. 5e). Together these data indicate that Cys116 is a critical
component of a novel zinc finger structure within the N-terminal
domain of ZBTB11 whose integrity is required for its activity as a
transcriptional repressor of its target, TP53.
Discussion
We have identified a role for the previously enigmatic Zbtb11
protein in myeloid development. The Zbtb11 requirement for
granulopoiesis is already apparent during primitive haemopoiesis
reflected by the paucity of neutrophils in mne compared to WT at
48 h.p.f. and this requirement continues into definitive haemo-
poiesis where haemopoietic stem cell-dependent neutrophil
expansion fails to occur in mne in response to immune challenge
or cytokine stimulation. Thus Zbtb11 appears to be important for
both basal and emergency granulopoiesis. That macrophage
number is indistinguishable between WT and mne at 48 h.p.f. and
that mne macrophages can reconstitute after ablation indicate
that intact Zbtb11 is dispensable for primitive macrophage
development but becomes rate-limiting as reliance on HSC self-
renewal and differentiation increases and becomes absolute
following the onset of definitive haemopoiesis. The differential
timing between neutrophil and macrophage depletion suggests
Zbtb11 has an essential role in establishing a full complement of
neutrophils, whereas with macrophage and other lineages,
the later depletion is reflective of a broad failure of myelopoiesis.
The positioning of ZBTB11 downstream of the master myeloid
regulators PU.1, C/EBPa and GFI1 in the haemopoietic
transcriptional hierarchy suggests ZBTB11 may potentially act
at the level of progenitors to direct proliferation, differentiation
and/or survival towards amplifying neutrophil number. This is
supported by the data showing that Zbtb11 dysfunction results
not only in a quantitative defect in neutrophils but also a
qualitative defect manifest in the high proportion of immature
neutrophil lineage cells in mne.
Although we have clearly positioned ZBTB11 within the
haemopoietic transcription factor hierarchy, its precise mechan-
ism of action remains elusive. Pathway analysis generated from
RNAseq data from mne versus WT neutrophils reveals central
roles for Zbtb11 in RNA processing, DNA replication and repair
as well as cell death and survival, and we have presented
functional data validating roles in both DNA replication and
cell death, where Zbtb11 deficiency results in markedly
increased apoptosis and virtually absent DNA synthesis. Studies
describing a role for TP53 in haematopoiesis, specifically the
granulocytopenia accompanying overexpression of Trp53 in
the Mdm2 knockout mouse9, prompted us to study whether
the upregulation of tp53 in mne was in response to cell stress or
whether it was due to derepression in the absence of fully
functional Zbtb11. The biochemical evidence shows that not only
does ZBTB11 repress TP53 but that it requires Cys116 for this
function, suggesting that the high levels of Tp53 in mne may at
least in part be due to derepression of tp53 by mutant Zbtb11.
Van Nostrand et al.32 showed that ectopic expression of Trp53
during development results in a pleiotrophic phenotype similar to
that seen in the CHARGE syndrome in humans, including
craniofacial, cardiac and eye defects. Many aspects of this
phenotype are mirrored in mne, and may partially explain the
Figure 4 | ZBTB11 is regulated by myeloid transcription factors and directly represses TP53. (a) Transient co-transfection of human ZBTB11 2.9 kb
promoter luciferase reporter and transcription factors into 293T cells shows ZBTB11 is regulated by PU.1 (positively) and GFI1a/b (negatively). Triangles
represent increasing concentration of transcription factors (n¼ 3 experiments; mean ±s.e.m.; two-way ANOVA). (b) A zebrafish zbtb11 2.3 kb promoter
reporter is positively regulated by Pu.1 and C/ebpa, and negatively regulated by all three Gfi1 paralogs. Triangles represent increasing concentration of
transcription factors (n¼ 3 experiments; mean±s.e.m.; two-way ANOVA). (c) ChIPseq shows PU.1 occupies the Zbtb11 locus in mouse granulocytes at the
promoter, 50 untranslated region of exon 1 and within intron 1. (d) Whole-mount in situ hybridization shows overexpression of D113p53 in the brain at
48 h.p.f. in mne but not phenotypically WT sibling embryos. (e) Transient co-transfection of ZBTB11 and a human TP53 luciferase reporter into 293T cells
shows direct repression of TP53 by ZBTB11. Triangle represents increasing concentration of ZBTB11 (n¼ 3 experiments; mean±s.e.m.; two-way ANOVA).
(f) ZBTB11 is enriched at the TP53 locus by ChIP–qPCR in human K562 (endogenous ZBTB11) and 293T HEK cells (overexpressed mouse ZBTB11). Using
four primer sets tiled across the TP53 promoter, primer set 1 yields little enrichment over normal rabbit serum control, while primer sets 2–4 show 12–25-
fold enrichment (K562: n¼ 5 experiments, mean±s.e.m.; 293T: n¼ 2 experiments, mean±s.e.m.). (g) Antisense morpholino oligonucleotide knockdown
of tp53 suppresses excessive apoptosis and increases neutrophil number in mne embryos. (h) Quantification of mne neutrophils in control and tp53
morphants (n¼ 3 experiments; mean ±s.e.m.; two-tailed paired t-test). (i) Quantification of mne neutrophils in tp53 WT and tp53M214K/M214K at 2 and
5 d.p.f.; (n¼ 3 experiments; two-tailed paired t-test). (j) Cell death marked by Annexin secA5-mVenus is prominent in mne CNS on tp53 WT background
and rescued on mne/ tp53M214K/M214K. (k) 2 2 Contingency table w2 analysis shows rescue of CNS cell death in mne on the tp53M214K/M214K mutant
background. Data for three independent experiments; Exp1, n¼ 13, 14; Exp2, n¼9, 20; Exp3, n¼ 11, 17; exact P values are shown. Where indicated:
*Pr0.05; **Pr0.01; ***Pr0.001; ****Pr0.0001; scale bars, 300 mm (d), 200 mm (g,j).
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pleiotropism that results from Zbtb11 dysfunction and high levels
of Tp53 during development in mne.
Knockdown of tp53 overexpression in mne by a widely used
and extensively characterized translation-blocking morpholino
partially rescued neutrophil number, pointing to a novel Pu.1–
Zbtb11–Tp53 pathway for regulation of neutrophil development.
This observation was in contrast to the tp53 mutant data, which
demonstrated that in the context of a tp53M214K/M214K allele
encoding transcriptionally dead Tp53 protein, neutrophil number
was not normalized in mne. Discrepancies between morpholino
knockdown and stable genetic mutant phenotypes have been
highlighted recently33 but do not necessarily mean that either
outcome is incorrect34. Indeed, accurate interpretation of TP53
data has been notoriously challenging. What could these two
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observations mean? It is possible that morpholino knockdown
corrects the overly high levels of Tp53 in mne to a subtle level that
allows for amelioration of the neutrophil deficit, while genetic
inactivation of tp53 removes the normal level of control achieved
by low levels of Tp53 and presents a different regulatory
landscape that prevents rescue of the neutrophil deficiency.
It is also possible that compensatory mechanisms by TP53
family members p63 and p73 may come into play in the tp53
mutant35–37. It is well known that TP53 is increased in response
to various types of cell stress including nucleolar stress,
which affects erythropoietic output in Diamond Blackfan
Anemia38–41. Could the mne phenotype be attributable solely
to stress response overexpression of Tp53? Neither the genetic
inactivation nor morpholino knockdown data can rescue mne
gross morphological defects, which strongly supports the notion
that the phenotype observed in mne is not due solely to activation
of Tp53 stress response pathways and that Zbtb11 can exert its
biological effects through a Tp53-independent mechanism. With
regard to CNS cell death, the morpholino and genetic data are
corroborative, demonstrating that CNS cell death is dependent on
both an intact mne locus and functional tp53. This is consistent
with an additional role for the ZBTB11–TP53 pathway outside of
haemopoietic development.
We sought to investigate whether the requirement for zbtb11
during zebrafish myeloid development was cell-autonomous by
transient overexpression approaches. However, we were not able
to confirm reliable, reproducible expression of Zbtb11–GFP
targeted to myeloid cells from transient, mosaic expression, even
using a Gal4/UAS approach in an attempt to amplify the signal.
Future endeavours to address this issue experimentally will
require stable transgenic approaches optimized for Zbtb11
reporter expression in zebrafish, or approaches in other animal
models.
The non-catalytic HHCC domain that resides in the
N-terminal domain of retrovirus and related retrotransposon
integrases, such as HIV-1 (human immunodeficiency virus 1), is
crucial for determining the conformation and therefore activity of
the integrase and infectivity of the virus42. The tetrahedral
coordination of a single zinc ion by the His and Cys residues in
this domain stabilizes the integrase allowing multimerization and
more effective catalytic activity. The canonical zinc binding motif
is HX3–7H(X23–32)CX2C (ref. 43). Studies of HIV-1 integrase have
revealed two distinct interconverting D- and E-conformations
that are determined as a result of how the HHCC domain
specifically coordinates a Zn2þ ion, underscoring the importance
of the HHCC domain for overall function of integrase44,45. The
surprising identification of a new HHCC (HX6H(X29)CX2C) zinc
finger in the N-terminal domain of Zbtb11 that underpins its
function as a transcriptional repressor provides the first
functional data for the HHCC domain in a human protein. The
evolutionary conservation of the HHCC motif across 422
vertebrate species of Zbtb11 further highlights its importance for
function. The identification of a cellular function for the HHCC
domain in Zbtb11 supports the previously untested hypothesis31
that the homologous uncharacterized HHCC domain in
NYNRIN and GIN1 also performs a cellular function. The
different possibilities for HHCC tetrahedral coordination of the
Zn2þ ion identified in HIV-1 integrase and the functional
consequences for enzyme activity, suggest a complex novel
regulatory role mediated through this domain. This complexity is
reflected in the Zbtb11 in vivo bioassay data, where the absence of
the HHCC domain allows Zbtb11 to rescue the mne phenotype
but mutation of any of the four metal ion-coordinating amino
acids does not. The notion that steric hindrance by an incorrectly
folded N terminus is potentially more detrimental than its
complete absence has previously been documented46, and in the
case of zinc finger proteins is supported by evidence showing that
metal coordination participates early in the folding process and is
critical for proper folding of these proteins47,48. We propose that
misfolding of the N terminus incurs a more severe penalty on
Zbtb11 protein folding integrity and stability than complete
absence of the N terminus, which may still allow for correct
modular folding of the remaining protein domains. However, this
question will only be resolved by biophysical data. Since removal
of the C-terminal zinc fingers remarkably does not appear to
impede function, either in our in vivo bioassay or a single
previous in vitro study19, the newly identified HHCC zinc finger
could serve to preserve Zbtb11 function in this context. It is
thought that in viruses this zinc finger recognizes viral DNA42
and we have shown a requirement for the intact HHCC domain
for recognition of cellular DNA through the transrepression and
autorepression functions of Zbtb11. It remains an intriguing
possibility that the cellular HHCC domain may also recognize
viral DNA, potentially as part of the host immune response.
Zbtb11 is a previously under-studied protein to which we now
ascribe a biological function squarely positioning it within the
haemopoietic transcription factor hierarchy as a regulator of basal
neutrophil development and emergency granulopoiesis. In
addition, we have identified a genetic and biochemical pathway
connecting ZBTB11 and TP53 that now merits consideration in
all tissues in which both Tp53 and Zbtb11 are expressed. Lastly,
we have identified a novel integrase-like HHCC domain in
Zbtb11. To our knowledge, we have provided the first cellular
function for this domain in a human protein, specifically the
transcriptional repressor activity of Zbtb11, with potential
functional implications for regulatory domains of other human
proteins. Together, these studies provide a basis for under-
standing how Zbtb11 dysregulation may contribute to disease
pathogenesis and opens a new window on virally derived cellular
domain function.
Methods
Animals. Strains: St Kilda Wild Type (SKWT; local pet shop, St Kilda, Victoria,
Australia), WIK, AB, AB* (Zebrafish International Research Centre, Eugene,
Oregon, USA) and Tu¨bingen (Max-Planck-Institut fu¨r Entwicklungsbiologie,
Tu¨bingen, Germany). Marsanne (mnegl11) is a novel mutant isolated from an
ethylnitrosourea (ENU) mutagenesis screen49. Primary transgenic lines were as
follows: Tg(mpx:EGFP)i114 (ref. 50), Tg(lyz:dsRed)nz50Tg (ref. 51),
Tg(gata1a:dsRed)sd2Tg (ref. 52), Tg(ubi:secAnnexinV-mVenus)mq8Tg (ref. 53),
Tg(mpeg1:Gal4FF)gl26 (ref. 54) and Tg(UAS:nfsb-mCherry)c264 (Zebrafish
International Stock Center, Eugene, OR). Compound and mutant lines were
generated by intercrossing. Fish were housed in the Ludwig Institute for Cancer
Research Aquarium and ARMI FishCore, and mice were housed in the WEHI
mouse facility using standard husbandry practices. Experiments were performed
according to protocols approved by the Animal Ethics Committees of the Ludwig
Institute for Cancer Research, The Walter and Eliza Hall Institute of Medical
Research and Monash University.
Genotyping. From 48 h.p.f., mne embryos were readily recognized in a Mendelian
proportion by their pleiotropic phenotypes including small dark eyes, neural
opacity, enlarged fourth ventricle and neutropenia. Younger mne embryos were
genotyped by PCR–RFLP (restriction fragment length polymorphism) using exon 2
primers (oligonucleotides, Supplementary Table 1) in 20 ml reactions with Phusion
polymerase (New England Biolabs, MA) and supplied GC buffer; 95 C, 2min
followed by 45 cycles at 95, 60 and 72 C for 30, 30 and 60 s, respectively, and
1 cycle of 10min at 72 C. PCR products were digested with Nsi1, which digests
only the WT allele since the T-A mne allele abolishes this site, and digestion
products resolved alongside corresponding uncut sample by agarose gel
electrophoresis.
Positional cloning. Positional cloning was initiated by a genome scan on embryos
from an F2 generation WIK pedigree mapping pair, MX95 (ref. 55). Two
independent pools of 40 WT and 40 mutant embryos were scored against a panel
of simple sequence length polymorphism markers selected to give B10 cM
coverage across all chromosomes. Bulk segregant analysis placed mne on
chromosome 6. Genomic regions potentially closer to the mutant locus than the
closest linked simple sequence length polymorphism markers were identified and
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primers designed to amplifyB1–1.5 kb products by PCR from individual mapping
pairs. Direct sequencing of the PCR products allowed detection of single-nucleotide
polymorphisms in these regions. Single-nucleotide polymorphisms that generated
useful RFLPs were selected for scoring, and individual mutant embryos
recombinant at more distant markers were scored at these RFLPs. This narrowed
the genetic interval to a 50 kb region containing a single gene, zbtb11, which was
sequenced to identify the mutation underpinning mne. Supplementary Table 1 lists
oligonucleotide sequences used.
FACS sorting and RT–qPCR. Haemopoietic populations were obtained from
adult zebrafish whole kidney marrow from Tg(gata1-dsRed) transgenic animals.
Erythrocytes were sorted first on the basis of gata1-dsRed fluorescence and
remaining populations were sorted on the basis of their physical characteristics
(forward and side scatter). Triplicate sample replicates obtained from single
complementary DNAs were subjected to quantitative PCR using primers in
Supplementary Table 1. Results were normalized using the DDCt method, and
compared to expression in whole kidney marrow. The purity of the myeloid and
erythroid populations was directly confirmed by concurrent qPCR for expression
of gata1 and spi1, which demonstrated low/absent expression of gata1 in the
myeloid population and low/absent levels of spi1 in the erythroid population
(Supplementary Fig. 7).
Cloning. Primers for cloning are shown in Supplementary Table 1. In brief,
48 h.p.f. mne cDNA was used for PCR amplification of zebrafish zbtb11 cDNA. The
PCR product was cloned into pBluescript II SKþ (Stratagene) then directionally
cloned into pCS2þ ClaI/XhoI sites to generate mne-zbtb11-pCS2þ . Mutagenesis
was used to generate WT-zbtb11-pCS2þ from the mne zbtb11 clone. Human
ZBTB11 was amplified from K562 cells and mouse Zbtb11 was amplified from
mouse thymocyte cDNA (a kind gift from Dr Matthew McCormack). Human
(2.9 kb) and zebrafish (2.3 kb) Zbtb11 promoters were cloned from K562 and
zebrafish genomic DNA, using In-Fusion (Clontech) into pGL3-luc (Promega).
All constructs were verified by nucleotide sequencing.
Microinjections. Deletion and point mutation Zbtb11 constructs as carboxy-
terminal GFP fusions were synthesized by inverse PCR or mutagenesis
(QuickChange Lightning, Stratagene or Q5 mutagenesis, NEB) and sequence
verified (for primers see Supplementary Table 1). Capped mRNA for microinjec-
tion was synthesized from Not 1 linearized template using SP6 mMESSAGE
mMACHINE (Ambion). Fertilized 1- to 2-cell embryos were microinjected with
1–2 nl synthetic mRNA, Zbtb11 ATG morpholino oligonucleotide (MO), tp53
MO or control MO (250 mM in H2O; Gene Tools, Philomath, OR; see
Supplementary Table 1 for sequence) traced where appropriate by mixing 1:1 with
5% rhodamine–dextran (in 0.2M KCl).
In vivo bioassay. For the in vivo bioassay embryos from a mneþ / incross were
injected with WT (rescue control) or test Zbtb11 mRNA and seeded at B40
embryos/dish. To determine rescue, gross morphological phenotype was scored at
48 h.p.f. for all embryos and the percentage of mutant versus WT embryos was
determined for each Zbtb11 construct and compared against the non-injected
controls (Mendelian ratio of B25% mutants).
CRISPR/Cas alleles. Oligonucleotides for guide RNA (sgRNA) synthesis were
designed using CHOP–CHOP (sequence in Supplementary Table 1). A zbtb11-
specific oligonucleotide containing a T7 polymerase recognition sequence at the 50
end was annealed to the constant oligonucleotide (encoding the reverse comple-
ment of the tracrRNA tail) via an overlapping homologous region56. Nucleotides
were filled in by T4 DNA polymerase to create a double-stranded template for
sgRNA synthesis using T7 Polymerase. RNA integrity was monitored by gel
electrophoresis. Cas9 protein (New England Biolabs) complexed with sgRNA was
injected into either Tg(mpx:EGFP) or Tg(lyz:dsRed) embryos. Injected embryos
were screened genotypically by sequencing and phenotypically for the mne
phenotype. F0 embryos were raised and out-crossed onto mne to determine
founders containing non-complementing CRISPR alleles. Indel mutations were
characterized in the F1 generation.
Microarray. Total RNA was isolated from three biologically independent pools of
WT and marsanne embryos using Trizol/chloroform extraction and isopropanol
precipitation and treated with RNase-free DNase (Ambion). Any remaining phenol
was removed using an RNeasy micro kit (Qiagen). Samples were provided to the
Ramaciotti Centre for Genomics (University of New South Wales, Australia) for
QC and processing. Input was 100 ng of total RNA, samples were processed using
the Affymetrix WT Plus kit with no amplification and hybridization was to
Affymetrix Zebrafish Gene Array 1.0 ST (Affymetrix). Data were analysed using
Bioconductor (Bioconductor—Open Source Software for Bioinformatics
(http://www.bioconductor.org) Copyright 2017) and R version 3.2.5 (The R Project
for Statistical Computing (https://www.r-project.org/)) packages. Expression values
for all genes were calculated using the robust multi-array average method57. Data
for biological replicates clustered into their separate groups corresponding to WT
and marsanne. For the identification of genes with differential expression between
groups, fold-change cutoff (Z2.0) and P value cutoff (r0.05) were used for
differential expression.
WISH and O-dianisidine staining. WISH was performed using standard tech-
niques58. Staining of haemoglobin by O-dianisidine was performed for 15min at
RT in 0.6mgml 1 O-dianisidine, 0.01M sodium acetate (pH 4.5), 0.65% H2O2
and 40% vol/vol ethanol. Embryos were imaged on an Olympus MVX10
microscope and processed in Fiji59, where head and tail images of the same embryo
were spliced to maintain in-focus focal plane, a dashed line indicates the junction.
EdU labelling. Embryos were phenotyped at 48 h.p.f. and scored prior to labelling.
EdU incorporation was achieved by soaking embryos in 0.2mM EdU (5-ethynyl-
20-deoxyuridine; Invitrogen), 10% DMSO in E3 medium on ice for 60min. Fol-
lowing washing (3 5min in E3) and fixation in 4% PFA/PBS for 90min, embryos
were again washed (3 5min in PBST; 1 dH2O) and incubated in acetone at
 20 C for 7min, then permeabilized in 1% DMSO/1% Triton-X100/PBS for 1 h
at RT. EdU incorporation was detected by incubation in PBS/0.3% Triton-X100
containing 0.2mM Alexafluor-555 (Life Technologies), 0.1M L-ascorbic acid,
100mM Tris pH 8.5, and 2mM CuSO4 for 2 h at RT and washed (5 5min PBST)
prior to imaging. Embryos were imaged on an Olympus MVX10 fluorescence
microscope and the number of EdU positive cells in caudal haemopoietic tissue
counted in Fiji using the Find Maxima algorithm.
In vivo neutrophil and macrophage studies. Stimulation of granulopoiesis was
with microinjection of 0.1 and 0.05 ng csf3a mRNA or intravascular injection of
freeze-killed Talaromyces (formerly Penicillium) marneffei at 48 h.p.f. Inducible
macrophage ablation using Tg(mpeg1:Gal4FF/UAS:nfsb-mCherry/mpx:EGFP)
embryos generated by inter-crossing was achieved with 10mM metronidazole
(Sigma M3761) treatment beginning at 36 h.p.f. and continuing for 11 h. At
48 h.p.f., embryos were placed in fresh E3 medium and imaged (t¼ 0 h post
treatment (h.p.t.)) to enumerate macrophages and neutrophils, then incubated a
further 53 h.p.f. (t¼ 53 h.p.t.) and again imaged. Leukocyte numbers in the caudal
haemopoietic tissue region (posterior to end of yolk extension) were quantified
either by manual counting or by leukocyte units60.
Chromatin immunoprecipitation–quantitative PCR. ChIP of endogenous
ZBTB11 from K562 cells was performed on 1 107 cells grown to log phase and
cross-linked with 1% formaldehyde for 10min at RT then quenched in 0.125M
glycine. Sonication of the crude nuclear fraction was conducted for 10 rounds of
30 s on/30 s off using Bioruptor (Diagenode) to achieve chromatin fragmentation of
B550 bp. A polyclonal anti-ZBTB11 antibody validated for immunoprecipitation
(#A303-240A; Bethyl Laboratories) and Protein A Dynabeads were used for
chromatin immunoprecipitation. This antibody was also validated in-house by
immunoprecipitation of overexpressed human ZBTB11–GFP fusion proteins
followed by detection with anti-GFP antibody (Roche) on immunoblot. Following
reverse cross-linking overnight at 65 C, DNA was isolated and a PCR mix
containing SYBR green (Roche) was prepared according to the manufacturer’s
specifications using primer sets tiled across the TP53 promoter and negative
control primer sets (Supplementary Table 1), and 1 ml diluted template DNA.
qPCR was conducted on a 7500 Real-Time PCR machine (Applied Biosystems).
Overexpression of mouse ZBTB11 in 293T HEK cells and ChIP with a monoclonal
anti-mouse ZBTB11 antibody (WEHI) gave concordant enrichment of ZBTB11 at
the TP53 locus. Antibody was prepared by immunization of rats with mouse
ZBTB11 KLH-conjugated SSEESYRAILRYLTNERC peptide. ELISA positive
supernatants were tested by immunoblot for reactivity with mouse ZBTB11 and
cross-reactivity with human or zebrafish Zbtb11 (negative for both). The selected
clone (IC2) was validated by immunoprecipitation of overexpressed mouse
ZBTB11–GFP fusion protein (Supplementary Fig. 8). Ct values were obtained and
fold enrichment calculated taking into account primer amplification efficiency (AE)
using the DDCt method: fold enrichment¼AE (DDCt), where
DDCt¼ (Ct(TP53)Ct(Input)) (Ct(NRS)C(Input)).
Western blot. Fifty micrograms of cell lysate was electrophoresed on a denaturing
reducing 4–12% polyacrylamide gel. Protein was transferred to Immobilon-FL
membrane (Millipore), blocked for 2 h at RT in Odyssey blocking buffer (LI-COR)
prior to incubation with ab84058 (abcam) at 1:500 dilution overnight at 4 C.
Signal was detected by anti-rabbit IRDye-680LT secondary antibody (LI-COR) on
an Odyssey infrared detection system (LI-COR). See Supplementary Fig. 9 for
uncropped western blot.
RNA sequencing. At 48 h.p.f., single-cell suspensions were prepared from either
WT embryos or from phenotype-sorted mne, and neutrophils FACS sorted into
RNALater (Qiagen) on the basis of bright mpx:EGFP or lyz:dsRed fluorescence
(FlowCore, Monash University, Victoria, Australia). To confirm correct gating,
sample FACS-sorted populations were analysed under fluorescence microscopy
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and found to contain only fluorescent neutrophils. RNA was extracted from sorted
cells using RNeasy Micro (Qiagen) and provided to the MHTP Medical Genomics
facility (Monash Health Translational Precinct, Clayton, Australia) for QC, library
preparation and sequencing. Details in brief: unstranded barcoded libraries were
prepared using total RNA and Nugen Ovation RNA-Seq system V2 for amplifi-
cation and cDNA generation, followed by Ovation Ultralow System V2 for library
preparation. Hundred base pair paired-end sequencing was performed on Illumina
HiSeq2 generating B20M reads per sample. Data were QC’d using FastQC, ends
trimmed using Trimgalore and sequence aligned to the zebrafish genome
(GRCz10) using STAR. Counts were derived using HTseq-count and differentially
expressed genes determined using limmaþ voom with a FDR¼ 0.01 and logFC
cutoff of 2.0 using Degust v0.21 (David R. Powell, Victorian Bioinformatics
Consortium, Australia).
ChIP sequencing. FACS was used to isolate Ly6GþCD11bþ granulocytes from
the bone marrow of C57BL/6 mice. ChIP samples were prepared according to
the standard Millipore/Upstate protocol and using the polyclonal anti-Pu.1 IgG
(T-21 X: sc-352 X) from Santa Cruz. Libraries were prepared and sequenced using
the Illumina TruSeq workflow. Reads were aligned to the mm10 build of the Mus
musculus genome using Subread aligner61.
Protein homology modelling. Zbtb11 amino acids 1–200 were used in a blastP
homology search against the Protein Data Bank (PDB) resulting in 5/14 hits with
Cys at C116 position which aligned with Foamy virus intasome protein. Three
structures (PDB IDs: 3OYM, 3OYI, 3OYK) complexed with manganese were used
as a template for homology modelling of Zbtb11 amino acids 77–123. Alignment
was performed with Clustal version 2.0.9 (ref. 62) and modelling with Modeller
version 9.12 (ref. 63).
Luciferase assays. Promoter and increasing doses of transcription factor
(10–100 ng) were co-transfected using Fugene 6 (Roche) into 293T HEK cells,
maintaining the total amount of DNA constant. Transcription factors were all
subcloned into the same vector (pCS2þ ) and activity normalized against vector
alone. They were as follows: zebrafish: gata1 and scl (ref. 64), erg1 (ref. 65), Pu.1
(ref. 58), c/ebpa (ref. 66), and gfi1aa, ab and bb (ref. 67); mammalian transcription
factors: MSCV-PU.1-IRES-GFP, pENTR-GFI1 and pENTR-GFI1B (ref. 68), and
TP53 promoter pGL2-356bp (ref. 69). Dual luciferase assays were performed as per
manufacturer instructions (Promega) and analysed on a CLARIOStar (BMG
Labtech). Cell lines used in these studies were a kind gift of Professor Stephen M
Jane and were routinely monitored, and confirmed negative for mycoplasma.
Statistics. Group sizes were planned to be 410 embryos/genotype/experiment.
In practice, the number of embryos was often much greater and limited by the
maximum practical number of randomly selected embryos that could be analysed.
If group sizes were smaller, it was due to limited embryo availability or loss during
the experiment, and these were assumed to be randomly distributed across groups
unless otherwise stated. Where appropriate to the hypothesis being tested, embryos
were assigned as mutant or wild-type, either by phenotype and/or post hoc
molecular genotyping. Otherwise, embryos were randomly assigned to experi-
mental groups. For embryos o48 h.p.f., experiments were always blinded to gen-
otype and hence scored blind, with genotype determined and allocated post data
analysis. Descriptive and analytical statistics were prepared in Prism 6 (GraphPad
Software Inc). F-tests were used to determine variance, which was always similar
for parametric tests presented. Where variance was significantly different between
groups, non-parametric tests were used. Unless otherwise stated, data are fromZ3
experiments: (1) for luciferase assays: mean±s.e.m.; two-way ANOVA; Dunnett’s
multiple comparisons to determine significance of transcription factor versus
vector alone and Tukey’s multiple comparisons to determine significance between
doses of a given transcription factor; (2) for in vivo leukocyte studies: mean
±s.e.m., two-tailed t-test; (3) rescue experiments: w2 analysis. NS, P40.05;
*Pr0.05; **Pr0.01; ***Pr0.001; ****Pr0.0001.
Data availability. The microarray data sets generated during the current study are
available in the Gene Expression Omnibus repository, accession number
GSE94532. The authors declare that all remaining data supporting the findings of
this study are available within the article and its Supplementary Information Files
or from the corresponding author upon reasonable request.
References
1. Dancey, J. T., Deubelbeiss, K. A., Harker, L. A. & Finch, C. A. Neutrophil
kinetics in man. J. Clin. Invest. 58, 705–715 (1976).
2. Orkin, S. H. & Zon, L. I. Hematopoiesis: an evolving paradigm for stem cell
biology. Cell 132, 631–644 (2008).
3. Rosenbauer, F. & Tenen, D. G. Transcription factors in myeloid development:
balancing differentiation with transformation. Nat. Rev. Immunol. 7, 105–117
(2007).
4. Akashi, K., Traver, D., Miyamoto, T. & Weissman, I. L. A clonogenic common
myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193–197
(2000).
5. Manz, M. G. & Boettcher, S. Emergency granulopoiesis. Nat. Rev. Immunol. 14,
302–314 (2014).
6. Wolff, L. & Humeniuk, R. Concise review: erythroid versus myeloid lineage
commitment: regulating the master regulators. Stem Cells 31, 1237–1244
(2013).
7. Liu, Y. et al. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 4,
37–48 (2009).
8. Pant, V., Quintas-Cardama, A. & Lozano, G. The p53 pathway in
hematopoiesis: lessons from mouse models, implications for humans. Blood
120, 5118–5127 (2012).
9. Mendrysa, S. M. et al. mdm2 is critical for inhibition of p53 during
lymphopoiesis and the response to ionizing irradiation. Mol. Cell Biol. 23,
462–473 (2003).
10. Siggs, O. M. & Beutler, B. The BTB-ZF transcription factors. Cell Cycle 11,
3358–3369 (2012).
11. Chevrier, S. & Corcoran, L. M. BTB-ZF transcription factors, a growing
family of regulators of early and late B-cell development. Immunol. Cell Biol.
92, 481–488 (2014).
12. Beaulieu, A. M. & Sant’Angelo, D. B. The BTB-ZF family of transcription
factors: key regulators of lineage commitment and effector function
development in the immune system. J. Immunol. 187, 2841–2847 (2011).
13. Peukert, K. et al. An alternative pathway for gene regulation by Myc. EMBO J.
16, 5672–5686 (1997).
14. Kobayashi, A. et al. A combinatorial code for gene expression generated by
transcription factor Bach2 and MAZR (MAZ-related factor) through the
BTB/POZ domain. Mol. Cell. Biol. 20, 1733–1746 (2000).
15. Chen, Z. et al. Fusion between a novel Kruppel-like zinc finger gene and the
retinoic acid receptor-alpha locus due to a variant t(11;17) translocation
associated with acute promyelocytic leukaemia. EMBO J. 12, 1161–1167 (1993).
16. Suliman, B. A., Xu, D. & Williams, B. R. The promyelocytic leukemia zinc
finger protein: two decades of molecular oncology. Front. Oncol. 2, 74 (2012).
17. Su, A. I. et al. Large-scale analysis of the human and mouse transcriptomes.
Proc. Natl Acad. Sci. USA 99, 4465–4470 (2002).
18. Kilpinen, S. et al. Systematic bioinformatic analysis of expression levels of
17,330 human genes across 9,783 samples from 175 types of healthy and
pathological tissues. Genome Biol. 9, R139 (2008).
19. Tang, C., Westling, J. & Seto, E. trans repression of the human metallothionein
IIA gene promoter by PZ120, a novel 120-kilodalton zinc finger protein. Mol.
Cell. Biol. 19, 680–689 (1999).
20. Liu, Y. et al. Identification of differential expression of genes in hepatocellular
carcinoma by suppression subtractive hybridization combined cDNA
microarray. Oncol. Rep. 18, 943–951 (2007).
21. Nerlov, C. & Graf, T. PU.1 induces myeloid lineage commitment in multipotent
hematopoietic progenitors. Genes Dev. 12, 2403–2412 (1998).
22. Hock, H. et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in
neutrophil differentiation. Immunity 18, 109–120 (2003).
23. Wilson, N. K. et al. Combinatorial transcriptional control in blood stem/
progenitor cells: genome-wide analysis of ten major transcriptional regulators.
Cell Stem Cell 7, 532–544 (2010).
24. Bieging, K. T. & Attardi, L. D. Cancer: a piece of the p53 puzzle. Nature 520,
37–38 (2015).
25. Kruiswijk, F., Labuschagne, C. F. & Vousden, K. H. p53 in survival, death and
metabolic health: a lifeguard with a licence to kill. Nat. Rev. Mol. Cell Biol. 16,
393–405 (2015).
26. Chen, J. et al. p53 isoform delta113p53 is a p53 target gene that antagonizes p53
apoptotic activity via BclxL activation in zebrafish. Genes Dev. 23, 278–290
(2009).
27. Stogios, P. J., Downs, G. S., Jauhal, J. J., Nandra, S. K. & Prive, G. G. Sequence
and structural analysis of BTB domain proteins. Genome Biol. 6, R82 (2005).
28. Moore, S. P. & Garfinkel, D. J. Functional analysis of N-terminal residues of ty1
integrase. J. Virol. 83, 9502–9511 (2009).
29. Mendiratta, G., Eriksson, P. R., Shen, C. H. & Clark, D. J. The DNA-binding
domain of the yeast Spt10p activator includes a zinc finger that is homologous
to foamy virus integrase. J. Biol. Chem. 281, 7040–7048 (2006).
30. Llorens, C. & Marin, I. A mammalian gene evolved from the integrase domain
of an LTR retrotransposon. Mol. Biol. Evol. 18, 1597–1600 (2001).
31. Marco, A. & Marin, I. CGIN1: a retroviral contribution to mammalian
genomes. Mol. Biol. Evol. 26, 2167–2170 (2009).
32. Van Nostrand, J. L. et al. Inappropriate p53 activation during development
induces features of CHARGE syndrome. Nature 514, 228–232 (2014).
33. Kok, F. O. et al. Reverse genetic screening reveals poor correlation between
morpholino-induced and mutant phenotypes in zebrafish. Dev. Cell 32, 97–108
(2015).
34. Rossi, A. et al. Genetic compensation induced by deleterious mutations but not
gene knockdowns. Nature 524, 230–233 (2015).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14911
12 NATURE COMMUNICATIONS | 8:14911 | DOI: 10.1038/ncomms14911 | www.nature.com/naturecommunications
35. Celli, J. et al. Heterozygous germline mutations in the p53 homolog p63 are the
cause of EEC syndrome. Cell 99, 143–153 (1999).
36. Yang, A. et al. p63 is essential for regenerative proliferation in limb, craniofacial
and epithelial development. Nature 398, 714–718 (1999).
37. Yang, A. et al. p73-deficient mice have neurological, pheromonal and
inflammatory defects but lack spontaneous tumours. Nature 404, 99–103
(2000).
38. Ruggero, D. Revisiting the nucleolus: from marker to dynamic integrator of
cancer signaling. Sci. Signal 5, pe38 (2012).
39. Ellis, S. R. & Gleizes, P. E. Diamond Blackfan anemia: ribosomal proteins going
rogue. Sem. Hematol. 48, 89–96 (2011).
40. Danilova, N., Sakamoto, K. M. & Lin, S. Ribosomal protein S19 deficiency in
zebrafish leads to developmental abnormalities and defective erythropoiesis
through activation of p53 protein family. Blood 112, 5228–5237 (2008).
41. Uechi, T. et al. Deficiency of ribosomal protein S19 during early embryogenesis
leads to reduction of erythrocytes in a zebrafish model of Diamond-Blackfan
anemia. Hum. Mol. Genet. 17, 3204–3211 (2008).
42. Zheng, R., Jenkins, T. M. & Craigie, R. Zinc folds the N-terminal domain of
HIV-1 integrase, promotes multimerization, and enhances catalytic activity.
Proc. Natl Acad. Sci. USA 93, 13659–13664 (1996).
43. Burke, C. J. et al. Structural implications of spectroscopic characterization
of a putative zinc finger peptide from HIV-1 integrase. J. Biol. Chem. 267,
9639–9644 (1992).
44. Cai, M. et al. Solution structure of the His12 --4 Cys mutant of the N-terminal
zinc binding domain of HIV-1 integrase complexed to cadmium. Protein Sci. 7,
2669–2674 (1998).
45. Cai, M. et al. Solution structure of the N-terminal zinc binding domain of
HIV-1 integrase. Nat. Struct. Biol. 4, 567–577 (1997).
46. di Masi, A. May a missense mutation be more deleterious than a truncating
mutation? IUBMB Life 60, 79–81 (2008).
47. Reddi, A. R., Guzman, T. R., Breece, R. M., Tierney, D. L. & Gibney, B. R.
Deducing the energetic cost of protein folding in zinc finger proteins using
designed metallopeptides. J. Am. Chem. Soc. 129, 12815–12827 (2007).
48. Li, W., Zhang, J., Wang, J. & Wang, W. Metal-coupled folding of Cys2His2
zinc-finger. J. Am. Chem. Soc. 130, 892–900 (2008).
49. Hogan, B. M. et al. Specification of the primitive myeloid precursor pool
requires signaling through Alk8 in zebrafish. Curr. Biol. 16, 506–511 (2006).
50. Renshaw, S. A., Loynes, C. A., Elworthy, S., Ingham, P. W. & Whyte, M. K. B.
Modeling inflammation in the zebrafish: how a fish can help us understand
lung disease. Exp. Lung Res. 33, 549–554 (2007).
51. Hall, C., Flores, M. V., Storm, T., Crosier, K. & Crosier, P. The zebrafish
lysozyme C promoter drives myeloid-specific expression in transgenic fish.
BMC Dev. Biol. 7, 42 (2007).
52. Yaqoob, N., Holotta, M., Prem, C., Kopp, R. & Schwerte, T. Ontogenetic
development of erythropoiesis can be studied non-invasively in GATA-1:DsRed
transgenic zebrafish. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 154,
270–278 (2009).
53. Morsch, M. et al. In vivo characterization of microglial engulfment of dying
neurons in the zebrafish spinal cord. Front Cell. Neurosci. 9, 321 (2015).
54. Ellett, F., Pase, L., Hayman, J. W., Andrianopoulos, A. & Lieschke, G. J. mpeg1
promoter transgenes direct macrophage-lineage expression in zebrafish. Blood
117, e49–e56 (2011).
55. Keightley, M. C. et al. In vivo mutation of pre-mRNA processing factor 8
(Prpf8) affects transcript splicing, cell survival and myeloid differentiation.
FEBS Lett. 587, 2150–2157 (2013).
56. Gagnon, J. A. et al. Efficient mutagenesis by Cas9 protein-mediated
oligonucleotide insertion and large-scale assessment of single-guide RNAs.
PLoS ONE 9, e98186 (2014).
57. Irizarry, R. A. et al. Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics 4, 249–264 (2003).
58. Lieschke, G. J. et al. Zebrafish SPI-1 (PU.1) marks a site of myeloid
development independent of primitive erythropoiesis: implications for axial
patterning. Dev. Biol. 246, 274–295 (2002).
59. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis.
Nat. Methods 9, 676–682 (2012).
60. Ellett, F. & Lieschke, G. J. Computational quantification of fluorescent
leukocyte numbers in zebrafish embryos. Methods Enzymol. 506, 425–435
(2012).
61. Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and scalable
read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).
62. Larkin, M. A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23,
2947–2948 (2007).
63. Eswar, N. et al. Comparative protein structure modeling using MODELLER.
Curr. Protoc. Protein Sci. Chapter 2, Unit 2.9 (2007).
64. Gering, M., Rodaway, A. R., Gottgens, B., Patient, R. K. & Green, A. R. The SCL
gene specifies haemangioblast development from early mesoderm. EMBO J. 17,
4029–4045 (1998).
65. Ellett, F., Kile, B. T. & Lieschke, G. J. The role of the ETS factor erg in zebrafish
vasculogenesis. Mech. Dev. 126, 220–229 (2009).
66. Lyons, S. E., Shue, B. C., Oates, A. C., Zon, L. I. & Liu, P. P. A novel myeloid-
restricted zebrafish CCAAT/enhancer-binding protein with a potent
transcriptional activation domain. Blood 97, 2611–2617 (2001).
67. Cooney, J. D. et al. Teleost growth factor independence (gfi) genes differentially
regulate successive waves of hematopoiesis. Dev. Biol. 373, 431–441 (2013).
68. Lim, J. et al. A protein-protein interaction network for human inherited ataxias
and disorders of Purkinje cell degeneration. Cell 125, 801–814 (2006).
69. Wang, S. & El-Deiry, W. S. p73 or p53 directly regulates human p53
transcription to maintain cell cycle checkpoints. Cancer Res. 66, 6982–6989
(2006).
70. Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. & Schilling, T. F.
Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253–310
(1995).
Acknowledgements
We thank A. Burgess, W. Alexander, N. Nicola, S. Jane for advice and support, especially
early in the project; F. Ellett for advice and assistance, S. Varma, L. Kapitany, J. Hayman,
J. Kwek, M. Le Moing, for expert technical assistance; M. Ramialison for advice regarding
microarray and RNAseq analysis; J. Polo for critical reading of the manuscript; J. Kaslin
and B. Lindsey for EdU protocol; the following people for reagents: A. Andrianopoulos,
University of Melbourne, Australia (T. marneffei spores), P. Bartunek, Charles Uni-
versity, Prague, CZ (csf3), Martin Gering, University of Nottingham, UK (gata1 and scl),
P. Liu, NIH, Bethesda MD, USA (c/ebpa); B. Paw, Harvard University, Boston MA, USA
(gfi1aa, ab and bb); pENTR-GFI1 and pENTR-GFI1B were gifts from H. Zoghbi
(Addgene plasmid #16,168 and #16,169), pGL2-356bp was a gift from W. El-Deiry
(Addgene plasmid #16,292); A. Hughes, K. Taylor, B. Groves, M. Greer, P. Chamberlain,
L. Richards, T. Blanch and all FishCore staff for animal care; Monash Micro Imaging,
FlowCore facilities for equipment and technical support.
This work was supported by the National Health and Medical Research Council
(234708 (G.J.L., J.E.L.), 280916 (J.K.H., G.J.L.), 406695 (D.P.C.), 637395 [G.J.L.], 1070687
(G.J.L., M.-C.K.), 461208 (G.J.L.), 1023529 (G.J.L.), 1044754 (G.J.L.), 1022688 (A.M.B.),
1034816 (N.J.C.), 1048278, 1058238 (S.L.N.)), ARC (DP0346823 (G.J.L., J.E.L., J.K.H.)),
Cancer Council Victoria (1047660 (G.J.L., M.-C.K.)), National Institutes of Health (R01
HL079545 (G.J.L.)). The Australian Regenerative Medicine Institute is supported by
funds from the State Government of Victoria and the Australian Federal Government.
Author contributions
Conceptualization: M.-C.K., D.P.C. and G.J.L. Investigation: M.-C.K. (characterization
and biochemistry), D.P.C. (positional cloning and initial characterization) and J.E.L.
(forward genetic screen). Formal analysis: M.-C.K., D.P.C., J.M. and A.M.B. Resources:
J.G.W., A.P.B., J.Y.B., A.D., A.P.B. and N.J.C. Supervision: M.-C.K., J.E.L., L.P., D.T.,
S.L.N., J.K.H. and G.J.L. Writing—original draft: M.-C.K. and G.J.L. Writing—review and
editing: all authors. Funding acquisition: M.-C.K., J.E.L., J.K.H. and G.J.L.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing interests: The authors declare no competing financial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Keightley, M.-C. et al. The Pu.1 target gene Zbtb11 regulates
neutrophil development through its integrase-like HHCC zinc finger. Nat. Commun. 8,
14911 doi: 10.1038/ncomms14911 (2017).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2017
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14911 ARTICLE
NATURE COMMUNICATIONS | 8:14911 | DOI: 10.1038/ncomms14911 | www.nature.com/naturecommunications 13
